Evidence map›Paper›PMID 24812437›Full record

ArticleDisease models & mechanisms2014

Zebrafish yolk lipid processing: a tractable tool for the study of vertebrate lipid transport and metabolism.

Rosa L Miyares, Vitor B de Rezende, Steven A Farber

Open access · goldAbstract read
In one paragraph

Article in Disease models & mechanisms, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 59 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
59citing papers in PubMed, 1 pooled it
4.7field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

59 citing papers in PubMed, 1 synthesis or guideline pooled it, 133 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Selective targeting of kinesin on lipid droplets in the liver reduces plasma lipids.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. International journal of molecular sciences · 2024
    Article
  13. Article
  14. Article
  15. Article
  16. Comparing the effects of developmental exposure to alpha lipoic acid (ALA) and perfluorooctanesulfonic acid (PFOS) in zebrafish (Danio rerio).Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association · 2024
    Article
  17. Article
  18. Article
  19. Article
  20. Origin, form and function of extraembryonic structures in teleost fishes.Philosophical transactions of the Royal Society of London. Series B, Biological sciences · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 2 countries.

Rosa L MiyaresDepartment of Embryology, Carnegie Institution for Science, Baltimore, MD 21218, USA. Department of Biology, Johns Hopkins University, Baltimore, MD 21218, USA.
Vitor B de RezendeDepartment of Mental Health, School of Medicine of Federal University of Minas Gerais, 30130-100 Belo Horizonte, Brazil.
Steven A FarberDepartment of Embryology, Carnegie Institution for Science, Baltimore, MD 21218, USA. farber@ciwemb.edu.
Carnegie Institution for Science · USUniversidade Federal de Minas Gerais · BR

Funding

CELLULAR AND MOLECULAR BIOLOGYT32GM007231 · NIGMS · JOHNS HOPKINS UNIVERSITY · PI VAN DOREN, MARK B · 1985 to 2020
$18.4M
Systematic Vertebrate Functional GenomicsR01GM063904 · NIGMS · UNIVERSITY OF TEXAS AT AUSTIN · PI EKKER, STEPHEN CARL · 2001 to 2025
$10.7M
JHU-UMD Diabetes Research CenterP30DK079637 · NIDDK · JOHNS HOPKINS UNIVERSITY · PI BRANCATI, FREDERICK L · 2013 to 2017
$9.7M
Identifying genes required for digestive physiology and lipid metabolismR01DK093399 · NIDDK · JOHNS HOPKINS UNIVERSITY · PI STEVEN A FARBER, John F Rawls · 2013 to 2026
$7.6M
Cellular and Molecular BiologyT32GM141804 · NIGMS · JOHNS HOPKINS UNIVERSITY · PI John Kim · 2021 to 2026
$5.1M
Fatty acid metabolism and signaling during zebrafish developmentF31DK079421 · NIDDK · CARNEGIE INSTITUTION OF WASHINGTON, D.C. · PI MIYARES, ROSA LINDA · 2007 to 2010
$91k
NIDDK NIH HHS F31 DK079421NIDDK NIH HHS F31DK079421NIDDK NIH HHS P30 DK079637NIDDK NIH HHS R01 DK093399NIDDK NIH HHS R01DK093399NIGMS NIH HHS R01 GM063904NIGMS NIH HHS R01GM63904NIGMS NIH HHS T32 GM007231NIGMS NIH HHS T32GM007231NIGMS NIH HHS T32 GM141804
6 · The paper itself

Abstract

Dyslipidemias are a major cause of morbidity and mortality in the world, particularly in developed nations. Investigating lipid and lipoprotein metabolism in experimentally tractable animal models is a crucial step towards understanding and treating human dyslipidemias. The zebrafish, a well-established embryological model, is emerging as a notable system for studies of lipid metabolism. Here, we describe the value of the lecithotrophic, or yolk-metabolizing, stages of the zebrafish as a model for studying lipid metabolism and lipoprotein transport. We demonstrate methods to assay yolk lipid metabolism in embryonic and larval zebrafish. Injection of labeled fatty acids into the zebrafish yolk promotes efficient uptake into the circulation and rapid metabolism. Using a genetic model for abetalipoproteinemia, we show that the uptake of labeled fatty acids into the circulation is dependent on lipoprotein production. Furthermore, we examine the metabolic fate of exogenously delivered fatty acids by assaying their incorporation into complex lipids. Moreover, we demonstrate that this technique is amenable to genetic and pharmacologic studies.

Indexed as

Lipid MetabolismAbsorption, PhysiologicalAnimalsBiological AssayBiological TransportBoron CompoundsEgg YolkEmbryonic DevelopmentEnzyme InhibitorsFatty AcidsHumansLarvaLipoproteins, LDLReproducibility of ResultsStaining and LabelingTime Factors4,4-difluoro-4-bora-3a,4a-diaza-s-indaceneBoron CompoundsEnzyme InhibitorsFatty AcidsLipoproteins, LDLZebrafish ProteinsDyslipidemiaLecithotrophicLipoproteinPlacentaYolk sacYolk syncytial layer

Identifiers

PMID24812437
PMCPMC4073280
OpenAlexW2122844026

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.